PL4072533T3 - Postać dawkowania zawierająca środek zasadowy i warstwę powłoki dojelitowej - Google Patents
Postać dawkowania zawierająca środek zasadowy i warstwę powłoki dojelitowejInfo
- Publication number
- PL4072533T3 PL4072533T3 PL20780967.4T PL20780967T PL4072533T3 PL 4072533 T3 PL4072533 T3 PL 4072533T3 PL 20780967 T PL20780967 T PL 20780967T PL 4072533 T3 PL4072533 T3 PL 4072533T3
- Authority
- PL
- Poland
- Prior art keywords
- coating layer
- dosage form
- enteric coating
- alkaline agent
- form containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201941051238 | 2019-12-11 | ||
| PCT/EP2020/075960 WO2021115648A1 (en) | 2019-12-11 | 2020-09-17 | Dosage form comprising an alkaline agent and an enteric coating layer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4072533T3 true PL4072533T3 (pl) | 2025-06-16 |
Family
ID=72659788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20780967.4T PL4072533T3 (pl) | 2019-12-11 | 2020-09-17 | Postać dawkowania zawierająca środek zasadowy i warstwę powłoki dojelitowej |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230000780A1 (pl) |
| EP (1) | EP4072533B1 (pl) |
| JP (1) | JP7754812B2 (pl) |
| KR (1) | KR20220113697A (pl) |
| CN (1) | CN114828833A (pl) |
| BR (1) | BR112022011130A2 (pl) |
| CA (1) | CA3160876A1 (pl) |
| ES (1) | ES3023309T3 (pl) |
| HU (1) | HUE070718T2 (pl) |
| IL (1) | IL293651B1 (pl) |
| MX (1) | MX2022007162A (pl) |
| PL (1) | PL4072533T3 (pl) |
| SI (1) | SI4072533T1 (pl) |
| WO (1) | WO2021115648A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102938078B1 (ko) | 2019-05-15 | 2026-03-11 | 에보닉 오퍼레이션스 게엠베하 | 캡슐 충전 기계를 사용한 셀룰로오스 또는 전분을 기반으로 하는 코팅을 갖는 충전된 경질 쉘 캡슐의 제조 방법 |
| CA3160869C (en) | 2019-12-11 | 2024-06-25 | Priyanka HAKSAR | Dosage form for use in treating or preventing of a disease |
| WO2023137556A1 (en) * | 2022-01-20 | 2023-07-27 | Bionxt Solutions Inc. | Chemical composition for enteric drug delivery |
| WO2023174722A1 (en) | 2022-03-15 | 2023-09-21 | Evonik Operations Gmbh | Pre-functionalized hard shell capsule with accelerated drug release at ph value 5 to 5.5 |
| EP4518841B1 (en) * | 2022-05-06 | 2025-12-17 | Evonik Operations GmbH | Dosage form with drug release at ph 3 to 6 using double coating system with at least one release acceleration agent |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
| US6500457B1 (en) * | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
| EP1677770A2 (en) * | 2003-10-31 | 2006-07-12 | Dexcel Ltd. | Stable lansoprazole formulation |
| CA2558535A1 (en) | 2004-03-03 | 2005-10-06 | Teva Pharmaceutical Industries Ltd. | A stable pharmaceutical composition comprising an acid labile drug |
| DE102005032806A1 (de) | 2005-07-12 | 2007-01-18 | Röhm Gmbh | Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten |
| DE102006035549A1 (de) | 2006-07-27 | 2008-01-31 | Evonik Röhm Gmbh | Arzneiform mit mindestens zweischichtiger Trennschicht |
| DK2152250T3 (da) | 2007-05-07 | 2019-12-09 | Evonik Degussa Gmbh | Faste doseringsformer, der omfatter et enterisk overtræk, med accelereret lægemiddelfrigivelse |
| AU2008282900B2 (en) * | 2007-07-27 | 2014-05-22 | Depomed, Inc. | Pulsatile gastric retentive dosage forms |
| CN102626398A (zh) * | 2012-04-18 | 2012-08-08 | 上海腾瑞制药有限公司 | 一种泮托拉唑钠肠溶片及其制备方法 |
| PL2871973T3 (pl) * | 2012-07-12 | 2019-02-28 | Novus International Inc. | Kompozycje matrycy i warstwy do ochrony środków bioaktywnych |
| CA2910865C (en) * | 2014-07-15 | 2016-11-29 | Isa Odidi | Compositions and methods for reducing overdose |
| CN105640915A (zh) * | 2016-03-02 | 2016-06-08 | 吉林修正药业新药开发有限公司 | 一种雷贝拉唑钠肠溶片及其制备工艺 |
| IL293653B1 (en) * | 2019-12-11 | 2026-01-01 | Evonik Operations Gmbh | A dosage form for use in therapy comprising a core, an intermediate layer, and an enteric coating in a defined ratio |
| CA3160869C (en) * | 2019-12-11 | 2024-06-25 | Priyanka HAKSAR | Dosage form for use in treating or preventing of a disease |
-
2020
- 2020-09-17 IL IL293651A patent/IL293651B1/en unknown
- 2020-09-17 WO PCT/EP2020/075960 patent/WO2021115648A1/en not_active Ceased
- 2020-09-17 MX MX2022007162A patent/MX2022007162A/es unknown
- 2020-09-17 SI SI202030587T patent/SI4072533T1/sl unknown
- 2020-09-17 ES ES20780967T patent/ES3023309T3/es active Active
- 2020-09-17 CN CN202080085430.1A patent/CN114828833A/zh active Pending
- 2020-09-17 EP EP20780967.4A patent/EP4072533B1/en active Active
- 2020-09-17 US US17/757,060 patent/US20230000780A1/en active Pending
- 2020-09-17 JP JP2022535765A patent/JP7754812B2/ja active Active
- 2020-09-17 PL PL20780967.4T patent/PL4072533T3/pl unknown
- 2020-09-17 CA CA3160876A patent/CA3160876A1/en active Pending
- 2020-09-17 HU HUE20780967A patent/HUE070718T2/hu unknown
- 2020-09-17 KR KR1020227019164A patent/KR20220113697A/ko active Pending
- 2020-09-17 BR BR112022011130A patent/BR112022011130A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN114828833A (zh) | 2022-07-29 |
| JP7754812B2 (ja) | 2025-10-15 |
| JP2023505714A (ja) | 2023-02-10 |
| EP4072533A1 (en) | 2022-10-19 |
| EP4072533B1 (en) | 2025-01-22 |
| IL293651A (en) | 2022-08-01 |
| CA3160876A1 (en) | 2021-06-17 |
| IL293651B1 (en) | 2026-01-01 |
| WO2021115648A1 (en) | 2021-06-17 |
| MX2022007162A (es) | 2022-07-12 |
| HUE070718T2 (hu) | 2025-06-28 |
| US20230000780A1 (en) | 2023-01-05 |
| SI4072533T1 (sl) | 2025-04-30 |
| ES3023309T3 (en) | 2025-05-30 |
| BR112022011130A2 (pt) | 2022-08-23 |
| KR20220113697A (ko) | 2022-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL4072533T3 (pl) | Postać dawkowania zawierająca środek zasadowy i warstwę powłoki dojelitowej | |
| LT3999506T (lt) | Parp1 inhibitoriai | |
| IL286248A (en) | Tyk2 inhibitors and uses thereof | |
| IL284799A (en) | Tyk2 inhibitors and uses thereof | |
| EP3978244A4 (en) | MULTILAYER FILM AND USE THEREOF | |
| EP3969526A4 (en) | COATING COMPOSITION AND ITS USES | |
| DK3567085T3 (da) | Coatingsammensætning og coatingfilm dannet deraf | |
| PL3571251T3 (pl) | Kompozycja powłokowa zapobiegająca porastaniu, podłoże powleczone taką kompozycją powłokową oraz zastosowanie takiej kompozycji powłokowej | |
| PL3939232T3 (pl) | Łagodzenie skutków ataków komputerowych | |
| SG11202004174YA (en) | Foul release coating composition, substrate coated with such coating composition, and use of such coating composition | |
| EP3756885A4 (en) | MULTI-LAYER FILM WITH GLARE PROTECTION HARD COATING | |
| EP4365250A4 (en) | Migration-preventing coating agent | |
| EP4119620A4 (en) | Antifouling coating composition | |
| EP3932407C0 (en) | ENTERIC COATED TABLET COMPOSITION COMPRISING TETRAMETHYLPYRAZINE NITRONE | |
| EP3689977A4 (en) | COATING COMPOSITION AND COATING FILM | |
| EP3981596A4 (en) | COATING COMPOUNDS AND COATINGS | |
| EP3950865A4 (en) | COATING COMPOSITION | |
| EP3913022A4 (en) | ANCHOR COATING AGENT | |
| EP3903947A4 (en) | Paste coating device | |
| PL3834936T3 (pl) | Urządzenie i sposób powlekania podłoży warstwami pośrednimi | |
| EP3877437C0 (en) | COATING COMPOSITION | |
| IL289640A (en) | Antibodies binding igc2 of igsf11 (vsig3) and uses thereof | |
| EP3474824A4 (en) | GOOD SUCKABLE COATINGS AND SUBSTRATES COATED WITH THESE | |
| EP3950862A4 (en) | COATING COMPOSITION AND COATING FILM | |
| EP3977880C0 (en) | COAT |